The Sleepy Cannabinoid That Isn't: Zero Evidence That CBN Helps You Sleep

What Corroon Actually Did

Published in Cannabis and Cannabinoid Research in 2021, this review asked a question so basic it's almost embarrassing that it needed asking: is there any clinical evidence that CBN promotes sleep?

Corroon searched PubMed/MEDLINE for every human study involving cannabinol. He found 242 results total, 99 involving human subjects. From those, he identified eight that actually administered CBN to people and measured either sleep-related outcomes or THC-like subjective effects (since CBN is a THC degradation product, the question of whether it produces cannabis-like effects is directly relevant).

What the Eight Studies Found

The studies span from 1973 to 1987 — none are recent. Here's what each found when CBN was given to humans:

Read that list carefully. The largest study (Bird 1980, 161 participants) found nothing. The study that tested the highest doses (Gong 1984, up to 1,200 mg) found nothing. The study that specifically looked at drowsiness as an outcome (Karniol 1975) found it with THC but not CBN. And the study with the most sensitive route of administration (Johansson 1987, intravenous) found no psychoactive effects at all.

Not a single one of these studies used a validated sleep questionnaire. Not one used polysomnography. The entire clinical evidence base for "the sleepy cannabinoid" amounts to: we gave CBN to people in various ways, and they mostly didn't feel anything.

Where the Myth Came From

What CBN Actually Is, Pharmacologically

CBN is a partial agonist at the CB1 receptor — the same receptor THC activates — but with considerably lower binding affinity. In theory, this means CBN could produce mild, THC-like effects at sufficient doses. In practice, the doses required appear to be so large that they're impractical. Perez-Reyes' 1973 study found that intravenous CBN required doses "several orders of magnitude larger than those of delta-9-THC" to produce any cannabis-like effect.

Some preclinical (animal) studies have shown CBN prolonging barbiturate-induced sleep in mice — but this is a drug-drug interaction, not standalone sedation, and mouse models of sleep don't translate cleanly to humans. Other animal studies found no sedative effect at all.

The honest pharmacological summary: CBN is a weak cannabinoid that might produce mild effects at very high doses, has never been shown to promote sleep in a controlled human trial, and has no mechanism of action that would predict it to be a particularly effective sedative compared to THC, CBD, or dozens of other compounds.

The Industry Problem

This review matters beyond the pharmacology because it illuminates a structural problem in the cannabis industry.

Cannabis products are marketed as supplements and wellness products, not drugs. They don't require FDA approval, clinical trials, or evidence of efficacy before going to market. A manufacturer can put CBN in a gummy, label it as a sleep aid, price it at a premium, and sell millions of units without ever demonstrating that CBN does anything for sleep. The regulatory framework allows it. Consumer trust fills in the rest.

Corroon's conclusion was blunt: "Individuals seeking cannabis-derived sleep aids should be skeptical of manufacturers' claims of sleep-promoting effects."

This isn't unique to CBN — the cannabis industry regularly outpaces its evidence base. But CBN is perhaps the most egregious example: a product category worth hundreds of millions of dollars, built on a myth traceable to a five-person study from 1975 that didn't even support the claim being made.

Frequently Asked Questions

Should I stop buying CBN products for sleep?

If a CBN product helps you sleep, the benefit is likely coming from other ingredients (THC, CBD, terpenes like myrcene or linalool) or from placebo effect — not from CBN itself. There's nothing harmful about CBN, but you may be paying a premium for an ingredient that isn't doing what the label claims. A product with the same other ingredients minus the CBN would likely work identically.

Why do so many people say CBN helps them sleep?

CBN products almost always contain other cannabinoids and terpenes that do have sleep-relevant effects. THC reduces sleep onset latency. Myrcene is sedating. CBD reduces anxiety. When someone takes a "CBN gummy" and falls asleep, they're attributing the effect to the highlighted ingredient on the label rather than the full formulation. It's like attributing a multivitamin's effects to one ingredient listed in bold.

Could future research prove CBN helps with sleep?

It's possible but unlikely. The pharmacological profile of CBN — a weak partial CB1 agonist with low binding affinity — doesn't predict strong sedative effects. A well-designed RCT could test it, but given the existing data showing no signal across eight studies and doses up to 1,200mg, the odds of discovering a meaningful sleep effect are low.

Is there any harm in taking CBN?

CBN appears well-tolerated at the doses used in the studies reviewed (up to 1,200mg). At the much lower doses found in commercial products (typically 5-10mg), safety concerns are minimal. The harm is financial and opportunity-based: you're paying for an unproven ingredient, and you might delay finding approaches that actually work.